While current treatment options, including antibody-based drugs, offer some relief, they can be costly and not universally accessible. Alternative approaches, such as nucleic acid-based treatments ...

Hydrogels are polymeric materials with three-dimensional network structures containing large amounts of water. They serve as ...

Bio-Path (BPTH) announced the receipt of newly issued patents in the United States and New Zealand, and updated investors on the extent of its ...

First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable ...

Nucleic acid medicine allows for rational drug design and synthesis. “We can do it in the lab, we can do it fast, and we can scale it up,” he explains. “This is a huge transformation in how ...

Builds on Global Intellectual Property Portfolio to Protect DNAbilize® PlatformHOUSTON, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its ...

DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...

Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues in the human body.

Panel asks govt to ensure consistent supply of drugs, scaling up testing facilities against TB: Gireesh Babu, New Delhi Monday, February 10, 2025, 08:00 Hrs [IST] A Parliamentary ...